Christopher McMaster
Impact in
- Health Informatics top 10%
- Toxicology top 10%
- Pharmacovigilance and Adverse Drug Reactions
Papers in
-
- Rheumatoid Arthritis Research and Therapies 4
- Systemic Lupus Erythematosus Research 2
-
- Vasculitis and related conditions 5
- Co-authors
- David Liew (14 shared papers)Tue Wenzel Kragstrup (2 shared papers)Philip C. Robinson (3 shared papers)Russell Buchanan (7 shared papers)Claire Owen (7 shared papers)Bente Glintborg (1 shared paper)Bent Deleuran (1 shared paper)Wendy W. Chapman (2 shared papers)
- Journals
- Drug Safety (2 papers)European Journal of Nuclear Medicine and Molecular Imaging (2 papers)The Lancet Rheumatology (1 paper)Lara D. Veeken (1 paper)Journal of Biomedical Informatics (1 paper)
- Partner nations
- AustraliaUnited StatesDenmark
In The Last Decade
Christopher McMaster
18 papers receiving 296 citations
Peers
Comparison fields: 5 of 68
- Health Informatics 13
- Toxicology 27
- Rheumatology 89
- Geriatrics and Gerontology 13
- Dermatology 18
Countries citing papers authored by Christopher McMaster
This map shows the geographic impact of Christopher McMaster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher McMaster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher McMaster more than expected).
Fields of papers citing papers by Christopher McMaster
This network shows the impact of papers produced by Christopher McMaster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher McMaster. The network helps show where Christopher McMaster may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher McMaster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 68 | |
| 2 | 2022 | 42 | |
| 3 | 2020 | 33 | |
| 4 | 2023 | 32 | |
| 5 | 2019 | 30 | |
| 6 | 2022 | 28 | |
| 7 | 2022 | 25 | |
| 8 | 2023 | 14 | |
| 9 | 2020 | 11 | |
| 10 | 2024 | 6 | |
| 11 | 2022 | 5 | |
| 12 | 2022 | 3 | |
| 13 | 2023 | 2 | |
| 14 | 2025 | 1 | |
| 15 | 1994 | 1 | |
| 16 | 2022 | 1 | |
| 17 | 2022 | 1 | |
| 18 | 2018 | 1 |
About Christopher McMaster
Christopher McMaster is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine, Immunology, Toxicology and Physiology, having authored 18 papers that have together received 304 indexed citations. Recurring topics across this work include Vasculitis and related conditions (5 papers), Rheumatoid Arthritis Research and Therapies (4 papers), Pharmacovigilance and Adverse Drug Reactions (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Systemic Lupus Erythematosus Research (2 papers), Biosimilars and Bioanalytical Methods (2 papers), Academic integrity and plagiarism (1 paper) and Radiology practices and education (1 paper). The work is most often cited by research in Health Informatics (13 citations), Toxicology (27 citations), Rheumatology (89 citations), Geriatrics and Gerontology (13 citations) and Dermatology (18 citations). Christopher McMaster has collaborated with scholars based in Australia, United States and Denmark. Frequent co-authors include David Liew, Tue Wenzel Kragstrup, Philip C. Robinson, Russell Buchanan, Claire Owen, Bente Glintborg, Bent Deleuran, Wendy W. Chapman, Douglas E. V. Pires and Albert G. Frauman. Their work appears in journals such as Drug Safety, European Journal of Nuclear Medicine and Molecular Imaging, The Lancet Rheumatology, Lara D. Veeken and Journal of Biomedical Informatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.